Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
27,212,375
-
Share change
-
-3,096,368
-
Total reported value
-
$13,293,172
-
Price per share
-
$0.49
-
Number of holders
-
40
-
Value change
-
-$1,660,177
-
Number of buys
-
15
-
Number of sells
-
16
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q2 2022
As of 30 Jun 2022,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,212,375 shares.
The largest 10 holders included
BVF INC/IL, Nantahala Capital Management, LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, ALETHEA CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, 5AM Venture Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Knott David M Jr, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.